Synairgen (LON:SNG) Stock Crosses Below 200-Day Moving Average – What’s Next?

Shares of Synairgen plc (LON:SNG) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 3.43 ($0.04) and traded as low as GBX 1.81 ($0.02). Synairgen shares last traded at GBX 1.85 ($0.02), with a volume of 232,661 shares traded.

Synairgen Trading Up 1.0 %

The company has a market capitalization of £18.09 million, a PE ratio of -1.11 and a beta of -2.23. The company’s 50 day moving average price is GBX 2.13 and its 200-day moving average price is GBX 3.43.

Synairgen Company Profile

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease.

Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016).